| Literature DB >> 27437716 |
Natalia M Martinho1, Valéria R Silva1,2, Joseane Marques1,2, Leonardo C Carvalho1, Denise H Iunes1, Simone Botelho1,2.
Abstract
OBJECTIVE: To evaluate the effectiveness of abdominopelvic training by virtual reality compared to pelvic floor muscle training (PFMT) using a gym ball (a previously tested and efficient protocol) on postmenopausal women's pelvic floor muscle (PFM) strength.Entities:
Mesh:
Year: 2016 PMID: 27437716 PMCID: PMC4946841 DOI: 10.1590/bjpt-rbf.2014.0148
Source DB: PubMed Journal: Braz J Phys Ther ISSN: 1413-3555 Impact factor: 3.377
Figure 1Studied population. APT_VR: Abdominopelvic training by virtual reality; PFMT_GB: Pelvic floor muscle training using a gym ball.
Figure 2The participant’s position during abdominopelvic training by virtual reality. The virtual reality exercises were carried out, focusing on the abdominopelvic cavity, while sitting on a Wii Balance Board™. The participant was advised to perform different exercises using pelvic movements (anteversion, retroversion, lateral tilt, and circumduction), as well as, gently, contract the lower abdominal region (transversus abdominis muscle).
The clinical characteristics of the studied population.
|
|
| |
|---|---|---|
|
| 61.9 (8.6) | 61 (8.5) |
|
| 28.1 (3.9) | 28 (3.7) |
|
| ||
| No | 9 (30) | 9 (30) |
| Yes (twice per week) | 10 (33.3) | 8 (26.7) |
| Yes (3-7 times per week) | 11 (36.7) | 13 (43.3) |
|
| ||
| Absence | 9 (30) | 7 (23.3) |
| SUI symptoms | 3 (10) | 7 (23.3) |
| UUI symptoms | 8 (26.7) | 6 (20) |
| MUI symptoms | 10 (33.3) | 10 (33.4) |
|
| ||
|
| 13.3 (8.1) | 13 (8.5) |
|
| ||
| Have never had | 16 (53.3) | 16 (53.3) |
| Were
having | 4 (13.4) | 2 (6.7) |
| Had previously had | 10 (33.3) | 12 (40) |
|
| ||
|
| ||
| Nulliparous | 5 (16.7) | 3 (10) |
| Primiparous/Multiparous | 25 (83.3) | 27 (90) |
|
| 3.5 (2.7) | 3.9 (2.9) |
|
| ||
| Exclusively vaginal | 21 (70) | 14 (46.7) |
| Exclusively cesarean | 3 (10) | 7 (23.3) |
| Vaginal and cesarean | 3 (10) | 5 (16.7) |
| No delivery | 3 (10) | 4 (13.3) |
The data are presented in mean (M), standard deviation (SD) as well as absolute (f) and percent (%) frequencies. Personal, hormonal, and obstetric sample characteristics were presented for both statistical analysis: per-protocol analysis as well as intention-to-treat analysis. BMI: Body Mass Index; APT_VR: Abdominopelvic training by virtual reality; PFMT_GB: Pelvic floor muscle training using a gym ball; SUI: Stress urinary incontinence; UUI: Urgency urinary incontinence; MUI: Mixed urinary incontinence.
Hormone replacement therapy that has been stable for at least six consecutive months.
Pelvic floor muscle assessment by digital palpation, comparing pre and post training time as well as between groups, using both the per-protocol analysis as well as the intention-to-treat analysis.
|
| |||||
|---|---|---|---|---|---|
|
|
|
|
| ||
|
|
|
| 0.7 | ||
| 0 | 0 (0) | 0 (0) | |||
| 1 | 1 (4) | 0 (0) | |||
| 2 | 17 (63) | 8 (30) | |||
| 3 | 8 (30) | 15 (56) | |||
| 4 | 0 (0) | 3 (11) | |||
| 5 | 1 (4) | 1 (4) | |||
|
|
| ||||
| 0 | 0 (0) | 0 (0) | |||
| 1 | 4 (20) | 1 (5) | |||
| 2 | 6 (30) | 6 (30) | |||
| 3 | 7 (35) | 4 (20) | |||
| 4 | 3 (15) | 8 (40) | |||
| 5 | 0 (0) | 1 (5) | |||
|
|
|
| 0.7 | ||
| 0 | 0 (0) | 0 (0) | |||
| 1 | 2 (7) | 1 (3) | |||
| 2 | 18 (60) | 9 (30) | |||
| 3 | 8 (27) | 15 (50) | |||
| 4 | 1 (3) | 4 (14) | |||
| 5 | 1 (3) | 1 (3) | |||
|
|
| ||||
| 0 | 0 (0) | 0 (0) | |||
| 1 | 5 (17) | 2 (7) | |||
| 2 | 11 (36) | 11 (37) | |||
| 3 | 9 (30) | 6 (20) | |||
| 4 | 5 (17) | 10 (33) | |||
| 5 | 0 (0) | 1 (3) | |||
The table presents the evaluation and reevaluation times (pre and post-training evaluation) as well as a comparison between the studied groups (APT_VR versus PFMT_GB), using both the per-protocol analysis as well as the intention-to-treat analysis. The data were presented in absolute (f) and percent (%) frequencies. APT_VR: Abdominopelvic training by virtual reality; PFMT_GB: Pelvic floor muscle training using a gym ball.
Wilcoxon Test.
Mann-Whitney Test.
p≤0.05.
Pelvic floor muscle assessment by vaginal dynamometry, comparing pre- and post-training time as well as between groups, using both the per-protocol analysis and the intention-to-treat analysis.
|
|
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| |||
|
|
| –0.08 (MS) | –0.25 – 0.08 (MS) | 0.1( | 0.68 (MS) | 0.32 (MS) | ||||||
| Maximum
strength ( | 0.58 (0.4) | 0.67 (0.6) | 0.1 | 0.29 | 0.17 | |||||||
| Average
strength ( | 0.23 (0.2) | 0.28 (0.2) |
| 0.36 | 0.24 | |||||||
| Endurance ( | 3.12 (1.7) | 4.03 (2.4) |
| 0.57 | 0.42 | |||||||
|
| ||||||||||||
| Maximum
strength ( | 0.71 (0.3) | 0.89 (0.4) |
| 0.74 | 0.46 | |||||||
| Average
strength ( | 0.32 (0.1) | 0.34 (0.2) | 0.5 | 0.52 | 0.11 | |||||||
| Endurance ( | 4.27 (2.1) | 3.35 (1.7) |
| 0.75 | 0.48 | |||||||
|
|
| –0.03 (MS) | –0.16 – 0.09 (MS) | 0.5 ( | 0.52 (MS) | 0.14 (MS) | ||||||
| Maximum
strength ( | 0.57 (0.4) | 0.65 (0.5) | 0.1 | 0.56 | 0.16 | |||||||
| Average
strength ( | 0.2 (0.1) | 0.3 (0.2) |
| 0.6 | 0.21 | |||||||
| Endurance ( | 2.93 (1.7) | 3.73 (2.4) |
| 0.73 | 0.37 | |||||||
|
| ||||||||||||
| Maximum
strength ( | 0.63 (0.3) | 0.74 (0.4) |
| 0.67 | 0.29 | |||||||
| Average
strength ( | 0.3 (0.1) | 0.3 (0.1) | 0.5 | 0.51 | 0.06 | |||||||
| Endurance ( | 4.12 (2.1) | 3.54 (1.9) |
| 0.67 | 0.28 | |||||||
The table presents the evaluation and reevaluation times (pre and post-training evaluation) as well as a comparison between the studied groups (APT_VR versus PFMT_GB), using both the per-protocol analysis as well as the intention-to-treat analysis. The data were presented in mean (M) and standard deviation (SD). Note that some participants did not undergo PFM assessment by vaginal dynamometry due to their inability to perform the test due to pain/discomfort when the sensor was introduced. APT_VR: Abdominopelvic training by virtual reality; PFMT_GB: Pelvic floor muscle training using a gym ball; 95% CI: 95% Confidence Interval; Kgf: Kilogram/force; MS: Maximum strength; AS: Average strength; E: Endurance.
Wilcoxon Test.
Paired t Test.
Mann-Whitney Test.
p≤0.05.